Evaluation of correlation between -1562 C/T in promoter single nucleotide polymorphisms of MMP-9 gene and lung cancer initiation and metastasis risk

1. Lalloo F. (2002). Genetics for Oncologists: The Molecular Genetic Basis of Oncologic Disorders (Remedica Genetics). New York: Remedica Publishing. 2. Talmadge JE, Fidler IJ.(2010). AACR centennial series: the biology of cancer metastasis: historical perspective. Cancer Research; 70(14):5649–5669. 3. Gupta GP, Massague J.(2006). Cancer metastasis: building a framework. Cell. 127(4): 679-695. 4. Zahir ST, Mirtalebi M. (2012). Survival of patients with lung cancer, Yazd, Iran. Asian Pac J Cancer Prev.;13(9):4387-91. 5. Sternlicht MD, Werb Z.(2001). How matrix metalloproteinases regulate cell behavior. Annu Rev Cell Dev Biol.;17:463_516. 6. Tutton MG, George ML, Eccles SA, Burton S, Swift RI, Abulafi AM.(2003). Use of plasma MMP-2 andMMP-9 levels as a surrogate for tumor expression in colorectal cancer patients. IntJCancer;107:541^50. 7. Antonietta Rosella Farina and Andrew Reay Mackay.(2014). Gelatinase B/MMP-9 in Tumour Pathogenesis and Progression. Cancers (Basel). 6(1): 240–296. 8. S. Hughes, O. Agbaje, R. L. Bowen, et al. (2007). “Matrix metalloproteinase single-nucleotide polymorphisms and haplotypes predict breast cancer progression,” Clinical Cancer Research, vol. 13, no. 22, pp. 6673–6680. 9. Valko M, Rhodes CJ, Moncol J, Izakovic M, Mazur M. (2006) Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chem Biol Interact. 160(1): 1-40. 10. Joos L, He JQ, Shepherdson MB, Connett JE, Anthonisen NR, Pare PD, et al. (2002). The role of matrix metalloproteinase polymorphisms in the rate of decline in lung function. Hum Mol Genet. 11(5): 569-76. 11. Shields PG. (2007). Molecular epidemiology of smoking and lung cancer. Oncogene 2002; 21(45): 6870-6. 6. Schwartz AG, Prysak GM, Bock CH, Cote ML. The molecular epidemiology of lung cancer. Carcinogenesis. 28(3): 507-18. 12. Ii M, Yamamoto H, Adachi Y, Maruyama Y, Shinomura Y. (2006) Role of matrix metalloproteinase-7 (matrilysin) in human cancer invasion, apoptosis, growth, and angiogenesis. Exp Biol Med (Maywood ). 231(1): 20-7. 13. Yokota J. (2000) Tumor progression and metastasis. Carcinogenesis. 21(3): 497-503. 14. Zhang C, Li C, Zhu M, Zhang Q, Xie Z, Niu G, et al. (2013) Meta-analysis of MMP2, MMP3, and MMP9 promoter polymorphisms and head and neck cancer risk. PLoS One. 8(4): e62023. 15. Hongxia Li, Xiaoyan Liang, Xuebing Qin, Shaohua Cai & Senyang Yu. (2015). Association of matrix metalloproteinase family gene polymorphisms with lung cancer risk: logistic regression and generalized odds of published data. Scientific Reports, Article number: 10056. 16. Jafari M, Pirouzi A, Mohsenzadeh M, Kusari A A and Hajihosseini S. ( 2014). Association of MMP 9-1562 C/T Single Nucleotide Polymorphism with the Susceptibility to Lung Cancer Disease in South Iranian Population .British Journal of Medicine & Medical Research . 4(13): 2494-2502.